v3.26.3
SHARE-BASED PAYMENTS (Tables)
 12 Months Ended
Jun. 30, 2026
Disclosure of terms and conditions of share-based payment arrangement [abstract]  
Schedule of Equity Settled Share Based Payments
During fiscal 2026, fiscal 2025, and fiscal 2024 the following equity-settled share-based payments have been recognized in profit or loss:
202620252024
US$US$US$
Expense arising from staff remuneration arrangements(9,166,334)(9,568,191)(3,791,541)
Total expense arising from equity-settled share-based payment transactions(9,166,334)(9,568,191)(3,791,541)
Number and Weighted Average Exercise Prices of Options, Rights, and RSUs Granted
The following table illustrates the number and weighted-average exercise price of Options, and weighted-average grant date fair value for Rights and RSUs granted as share-based payments during fiscal 2026, fiscal 2025, and fiscal 2024:
Stock Option AwardsWA - Exercise Price A$Restricted Stock UnitsWA - Grant Date Fair Value A$Performance Rights Awards (market-based conditions)WA - Grant Date Fair Value A$Performance Rights Awards (performance conditions)WA - Grant Date Fair Value A$
June 30, 202323,011,3720.32 824,3710.95 26,910,0000.69 2,236,0001.04 
Granted-- 3,894,1242.18 3,980,0000.99 41,0001.10 
Exercised/Converted(11,262,000)(0.35)(341,461)(0.99)(4,726,665)(0.71)(421,000)(0.89)
Forfeited-- -- (550,000)(0.66)-- 
June 30, 202411,749,3720.28 4,377,0342.04 25,613,3350.74 1,856,0001.08 
Granted2,679,7466.46 2,220,0203.99 4,938,4093.49 350,0003.81 
Exercised/Converted(1,525,000)(0.20)(1,639,496)(1.93)(23,273,335)(0.79)(1,000,000)(1.24)
Forfeited-- (159,333)(2.27)(920,000)(0.98)(60,000)(0.91)
June 30, 202512,904,1181.57 4,798,2252.97 6,358,4092.66 1,146,0001.78 
Granted4,086,87118.40 853,9796.53 660,0772.66 109,0005.43 
Exercised/Converted(2,118,279)(0.62)(1,540,516)(2.23)-- (595,000)(1.53)
Forfeited(8,000,000)(0.20)(1,018)(6.91)-- (630,000)(2.45)
June 30, 20266,872,71013.47 4,110,6703.99 7,018,4862.66 30,0005.99 
The following Options, Rights and RSUs were granted as share-based payments during fiscal 2026, fiscal 2025, and fiscal 2024:
2026Security
 Type		NumberGrant DateExpiry
Date		Exercise
Price
A$		Vesting Hurdle
(30-day VWAP)
A$		Fair
Value
 A$
Series 1Rights45,0006-Aug-2531-Dec-26- 5.99 
Series 2RSUs118,87528-Nov-2523-Dec-26- - 5.11 
Series 3RSUs12,0005-Dec-2531-Dec-26- - 5.02 
Series 4Options235,0005-Dec-251-Apr-2710.00 - 0.40 
Series 5Rights64,00020-Dec-2531-Dec-25- - 5.03 
Series 6RSUs477,7525-Mar-2631-Dec-29- - 6.91 
Series 7Options511,9728-Mar-262-Apr-3011.00 - 2.93 
Series 8Options607,2448-Mar-262-Apr-3122.00 - 2.27 
Series 9Options536,5218-Mar-262-Apr-3118.00 - 2.57 
Series 10Rights226,0478-Mar-262-Apr-31- 18.00 4.47 
Series 11RSUs209,0328-Mar-262-Apr-30- - 6.55 
Series 12RSUs20,8209-Mar-262-Mar-28- - 6.55 
Series 13RSUs15,5009-Mar-262-Apr-28- - 6.55 
Series 14Options1,165,96519-Mar-262-Apr-3122.00 - 0.96 
Series 15Options1,030,16919-Mar-262-Apr-3118.00 - 1.11 
Series 16Rights434,03019-Mar-262-Apr-31- 18.00 1.72 
2025Security
 Type		NumberGrant DateExpiry
Date		Exercise
Price
A$		Vesting Hurdle
(30-day VWAP)
A$		Fair
Value
 A$
Series 1Rights445,0001-Nov-2431-Dec-27- 4.00 2.98 
Series 2Rights435,0001-Nov-2423-Apr-26- 3.00 3.12 
Series 3Rights585,0001-Nov-2423-Apr-26- 4.00 2.53 
Series 4Rights30,0001-Nov-2431-Dec-25- - 3.40 
Series 5Rights200,0001-Nov-2423-Apr-26- - 3.40 
Series 6RSUs25,1321-Nov-2431-Dec-27- - 3.40 
Series 7RSUs169,94422-Nov-2416-Dec-28- - 4.40 
Series 8Rights120,00020-Dec-2431-Dec-25- - 4.60 
Series 9RSUs42,4869-Mar-2516-Dec-28- - 3.37 
Series 10RSUs40,0006-May-2531-Dec-28- - 3.49 
Series 11RSUs113,4758-May-2531-Dec-28- - 3.40 
Series 12RSUs56,7389-May-2531-Dec-28- - 3.55 
Series 13RSUs82,33510-May-2510-Apr-29- - 3.55 
Series 14Options216,67210-May-2510-Apr-295.00 - 1.87 
Series 15RSUs13,61712-May-2531-Dec-28- - 3.41 
Series 16RSUs8,51113-May-2531-Dec-28- - 3.17 
Series 17RSUs400,53315-May-2510-Apr-29- - 3.11 
Series 18Rights415,69515-May-2510-Apr-31- 6.00 2.76 
Series 19Rights415,69515-May-2510-Apr-31- 7.00 2.68 
Series 20Rights415,69515-May-2510-Apr-31- 8.00 2.60 
Series 21RSUs48,22716-May-2531-Dec-28- - 3.20 
Series 22RSUs82,33523-May-2510-Apr-29- - 3.55 
Series 23Options216,67223-May-2510-Apr-295.00 - 1.86 
Series 24RSUs24,82329-May-2531-Dec-28- - 3.58 
Series 25RSUs9,36230-May-2531-Dec-28- - 3.69 
Series 26RSUs26,32631-May-2531-Dec-28- - 3.69 
Series 27RSUs357,73212-Jun-2510-Apr-29- - 4.10 
Series 28Options941,40212-Jun-2510-Apr-295.00 - 2.26 
Series 29RSUs3,40412-Jun-2531-Dec-28- - 4.10 
Series 30Options1,305,00026-Jun-2530-Jun-278.00 - 1.09 
Series 31RSUs715,04027-Jun-2510-Apr-29- - 4.75 
Series 32Rights742,10827-Jun-2510-Apr-31- 6.00 4.48 
Series 33Rights742,10827-Jun-2510-Apr-31- 7.00 4.38 
Series 34Rights742,10827-Jun-2510-Apr-31- 8.00 4.29 
2024Security
Type		NumberGrant DateExpiry
 Date		Exercise
Price
A$		Vesting Hurdle
(30-day VWAP)
A$		Fair
Value
A$
Series 1Shares116,53815-Aug-23-- - 0.98 
Series 2Rights21,00015-Aug-2322-Dec-24- - 1.10 
Series 3Rights10,00015-Aug-2322-Dec-25- - 1.10 
Series 4Rights10,00015-Aug-2322-Dec-26- - 1.10 
Series 5Rights200,00018-Dec-2323-Apr-26- 3.00 0.79 
Series 6Rights300,00018-Dec-2323-Apr-26- 4.00 0.63 
Series 7Rights3,330,00018-Dec-2321-Dec-28- 4.00 1.01 
Series 8Shares388,00030-Jan-24-- - 1.37 
Series 9Shares50,00030-Jan-24-- - 1.37 
Series 10RSUs1,434,00026-Mar-2431-Dec-27- - 2.27 
Series 11RSUs2,055,0009-Apr-2431-Dec-27- - 2.27 
Series 12RSUs405,12422-Nov-235-Dec-27- - 1.42 
Series 13Rights75,00021-May-2423-Apr-26- 3.00 1.61 
Series 14Rights75,00021-May-2423-Apr-26- 4.00 1.32 
Option Pricing Models
The fair value of granted Options is estimated as at the date of grant using the Black Scholes option valuation model taking into account the terms and conditions upon which the Unlisted Options were granted. The table below lists the inputs to the valuation models used for Options granted by the Group during fiscal 2026, fiscal 2025 and fiscal 2024:
202620252024
Expected life (weighted average)
4.16 years
2.96 years-
Risk-free interest rate (weighted average)
3.7%
3.28%-
Expected volatility (weighted average)
73%
80%-
Expected dividend yield
-%-%-
Right and RSU Pricing Models
The fair value of granted Rights that have market-based vesting conditions is estimated as at the date of grant using a trinomial valuation model taking into account the market-based vesting criteria upon which the Rights were granted. The table below lists the inputs to the valuation models used for the Rights that have market-based vesting conditions granted by the Group during fiscal 2026, fiscal 2025 and fiscal 2024:
202620252024
Expected life (weighted average)
4.98 years4.69 years4.56 years
Risk-free interest rate (weighted average)4.62%3.73%3.75%
Expected volatility (weighted average)75%77%80%
Fair value at grant date (weighted average)A$2.66A$3.49A$0.99
Share price at grant date (weighted average)A$4.58A$3.94A$1.36
Vesting hurdle (30-day VWAP) (weighted average)A$18.00A$6.02A$3.93